Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009
NBER Working Paper No. 18235
---- Acknowledgements -----
This research was supported by Pfizer. The sponsor placed no restrictions or limitations on data, methods, or conclusions, and had no right of review or control over the outcome of the research. The views expressed herein are those of the author and do not necessarily reflect the views of the National Bureau of Economic Research.